Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.000 | 100.200 | 0.200 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 8.632 | 11.086 |
Price to Book | 1.040 | 1.414 |
Price to Sales | 0.659 | 0.901 |
Price to Cash Flow | 4.887 | 6.079 |
Dividend Yield | 5.644 | 4.370 |
5 Years Earnings Growth | 8.296 | 10.402 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 31.400 | 20.534 |
Energy | 11.740 | 7.858 |
Industrials | 10.580 | 15.785 |
Consumer Cyclical | 10.340 | 8.869 |
Consumer Defensive | 9.240 | 9.486 |
Healthcare | 7.630 | 13.684 |
Basic Materials | 7.580 | 6.904 |
Utilities | 5.190 | 4.221 |
Communication Services | 5.120 | 6.530 |
Technology | 1.180 | 5.462 |
Number of long holdings: 110
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 4.64 | 29.55 | +0.96% | |
HSBC | GB0005405286 | 3.83 | 772.00 | +0.90% | |
TotalEnergies SE | FR0000120271 | 3.50 | 52.01 | +0.31% | |
Santander | ES0113900J37 | 2.75 | 4.3210 | -0.23% | |
UniCredit | IT0005239360 | 2.22 | 37.710 | +0.16% | |
Mercedes Benz Group | DE0007100000 | 2.20 | 52.720 | -1.37% | |
Novartis | CH0012005267 | 2.17 | 87.68 | +1.11% | |
Allianz | DE0008404005 | 2.15 | 294.20 | -0.14% | |
ING Groep | NL0011821202 | 1.97 | 14.83 | +0.54% | |
BNP Paribas | FR0000131104 | 1.95 | 57.54 | +0.17% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MEAG EuroInvest I | 16.89M | 11.60 | 4.96 | 8.06 | ||
MEAG EuroErtrag | 455.96M | 5.10 | 0.28 | 2.17 | ||
MEAG ProInvest | 387.77M | 11.19 | 3.25 | 6.98 | ||
MEAG GlobalBalance DF | 81.92M | 8.14 | 0.48 | 4.32 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review